Cytodyn Inc (CYDY)

[kgromax]

No, it's the opposite. For such a short trial, the only case where you need a sample size reassessment is when the hypothesized effect is not trending in the right direction and you have a doubt that, should it exist, you will have enough patients to correct the bad luck and detect the effect (with statistical significance). That reassessment allows you, ini emergency, to extend the trial by a couple more months, the time to recruit more patients (eg +100, +200, +300) to see if you had only bad luck or if the hypothesized effect finally appears.

It's a bad news against their initial hypothesis.